Oxford Nanopore Technologies (LON:ONT) Trading Down 10.2% – Here’s What Happened

by · The Cerbat Gem

Oxford Nanopore Technologies plc (LON:ONTGet Free Report)’s share price was down 10.2% on Monday . The company traded as low as GBX 127 ($1.60) and last traded at GBX 128.50 ($1.62). Approximately 3,354,197 shares were traded during mid-day trading, an increase of 54% from the average daily volume of 2,182,529 shares. The stock had previously closed at GBX 143.10 ($1.80).

Analyst Upgrades and Downgrades

A number of research firms have recently commented on ONT. Berenberg Bank restated a “buy” rating and set a GBX 282 ($3.54) target price on shares of Oxford Nanopore Technologies in a research report on Tuesday, September 3rd. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a GBX 190 ($2.39) price objective on shares of Oxford Nanopore Technologies in a report on Wednesday, September 4th. Finally, JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Oxford Nanopore Technologies in a research report on Friday, December 6th. Five analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock presently has an average rating of “Buy” and an average target price of GBX 235.50 ($2.96).

View Our Latest Stock Report on Oxford Nanopore Technologies

Oxford Nanopore Technologies Trading Down 10.2 %

The company has a fifty day moving average of GBX 142.50 and a 200-day moving average of GBX 129.63. The company has a market capitalization of £1.21 billion, a price-to-earnings ratio of -642.50 and a beta of 0.80. The company has a current ratio of 4.45, a quick ratio of 6.01 and a debt-to-equity ratio of 8.07.

Insider Buying and Selling at Oxford Nanopore Technologies

In other Oxford Nanopore Technologies news, insider Gurdial (Gordon) Sanghera sold 1,993,571 shares of the stock in a transaction dated Tuesday, October 15th. The shares were sold at an average price of GBX 142 ($1.78), for a total value of £2,830,870.82 ($3,558,158.40). In the last 90 days, insiders have bought 310 shares of company stock worth $45,010. Corporate insiders own 32.62% of the company’s stock.

About Oxford Nanopore Technologies

(Get Free Report)

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.

Featured Articles